Mometasone/salicylic acid

Drug Profile

Mometasone/salicylic acid

Alternative Names: Combisor; Mometasone furoate/salicylic acid; Monsalic; Salicylic acid/mometasone; Salicylic acid/mometasone furoate

Latest Information Update: 19 Sep 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Schering-Plough
  • Developer Merck & Co
  • Class Anti-inflammatories; Antipsoriatics; Glucocorticoids; Pregnadienediols; Salicylates
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Psoriasis; Skin disorders

Most Recent Events

No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top